Stephany J. Veuger

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition.

Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition.

Journal: PloS one

Published: October 09, 2025

Supporting quantitative skills in biomedical science with smart worksheets: intentions, impact and barriers to engagement.

Supporting quantitative skills in biomedical science with smart worksheets: intentions, impact and barriers to engagement.

Journal: British journal of biomedical science

Published: June 11, 2025

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron.

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron.

Journal: Journal of visualized experiments : JoVE

Published: March 11, 2024

Supporting the Biomedical Science UG Project Research Journey Through Staff-Student Partnerships.

Supporting the Biomedical Science UG Project Research Journey Through Staff-Student Partnerships.

Journal: British journal of biomedical science

Published: October 10, 2023

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling.

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling.

Journal: Cancers

Published: August 24, 2023

Effect of cyclic substituents on the anti-cancer activity and DNA interaction of ruthenium(II) bis-phenanthroline dipyridoquinoline.

Effect of cyclic substituents on the anti-cancer activity and DNA interaction of ruthenium(II) bis-phenanthroline dipyridoquinoline.

Journal: Frontiers in molecular biosciences

Published: July 03, 2023

Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines.

Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines.

Journal: Biomedicines

Published: May 31, 2023

Correction to: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance.

Correction to: Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance.

Journal: Oncogene

Published: January 26, 2023

Correction to: NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699.

Correction to: NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699.

Journal: Oncogene

Published: December 09, 2022

The Idiopathic Pulmonary Fibrosis-Associated Single Nucleotide Polymorphism RS35705950 Is Transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979.1).

The Idiopathic Pulmonary Fibrosis-Associated Single Nucleotide Polymorphism RS35705950 Is Transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979.1).

Journal: Non-coding RNA

Published: October 01, 2022

Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines.

Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines.

Journal: Frontiers in molecular biosciences

Published: July 27, 2022

A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma.

A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma.

Journal: Investigational new drugs

Published: January 12, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026